Mastodon

Vitrum® Kids (Tablets) Instructions for Use

Marketing Authorization Holder

Unipharm, Inc. (USA)

ATC Code

A11AA04 (Multivitamins and trace elements)

Dosage Form

Bottle OTC Icon Vitrum® Kids Chewable tablets: 30 or 60 pcs.

Dosage Form, Packaging, and Composition

Chewable tablets in the shape of animal figures from light pink to dark pink in color, with small inclusions of light and dark color, with a light fruity taste and smell.

1 tab.
Retinol acetate (vit. A) 2500 IU (860 mcg)
α-Tocopherol acetate (vit. E) 15 IU (15 mg)
Colecalciferol (vit. D3) 400 IU (10 mcg)
Ascorbic acid (vit. C) 60 mg
Thiamine mononitrate (vit. B1) 1.05 mg
Riboflavin (vit. B2) 1.2 mg
Calcium pantothenate (vit. B5) 5 mg
Pyridoxine hydrochloride (vit. B6) 1.05 mg
Folic acid (vit. B9) 300 mcg
Cyanocobalamin (vit. B12) 4.5 mcg
Nicotinamide (vit. PP) 13.5 mg
Biotin (vit. H) 20 mcg
Calcium (in the form of calcium carbonate) 100 mg
Magnesium (in the form of magnesium phosphate) 40 mg
Phosphorus (in the form of magnesium phosphate) 50 mg
Iron (in the form of iron fumarate) 15 mg
Copper (in the form of copper oxide) 1 mg
Zinc (in the form of zinc oxide) 10 mg
Manganese (in the form of manganese citrate) 1 mg
Iodine (in the form of potassium iodide) 150 mcg
Selenious acid solution 0.9% in 90% 2,2-dichloropropionic acid (in the form of sodium selenate) 25 mcg
Chromium (in the form of chromium aminoate) 20 mcg

Excipients: sucrose – 488.53 mg, stearic acid – 29.53 mg, colloidal silicon dioxide – 12 mg, magnesium stearate – 8 mg, strawberry flavor – 10 mg, sucralose – 1 mg, Allura Red AC dye (E129) – 1.6 mg.

30 pcs. – polyethylene bottles (1) – cardboard packs.
60 pcs. – polyethylene bottles (1) – cardboard packs.

Clinical-Pharmacological Group

Multivitamins with macro- and microelements

Pharmacotherapeutic Group

Multivitamin agent + multimineral

Pharmacological Action

A balanced complex of vitamins and minerals promotes healthy growth and mental development in children.

The specially selected doses correspond to the daily requirement of a child from 4 to 7 years old for vitamins, macro- and microelements.

The pharmacological action of the drug is determined by the properties of its constituent ingredients.

Indications

  • Prevention and treatment of vitamin deficiency and mineral deficiency in children during periods of intensive growth;
  • The period of recovery after past illnesses;
  • Unbalanced or inadequate nutrition, decreased appetite.

ICD codes

ICD-10 code Indication
E50-E64 Other types of nutritional deficiencies (E50-E64)
E63.1 Disparate intake of food elements
R63.0 Anorexia
Z54 Convalescence
ICD-11 code Indication
5B7Z Malnutrition, unspecified
MG43.7 Anorexia
QB7Z Convalescence, unspecified

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Administer orally after a meal to minimize potential gastrointestinal discomfort.

Chew the tablet thoroughly before swallowing; do not swallow it whole.

The dosage is one tablet per day.

This regimen is indicated specifically for children aged 4 to 7 years.

Do not administer to children under 4 years of age due to the risk of choking and inappropriate dosage.

Establish a fixed daily administration time to maintain consistent vitamin and mineral levels.

Strictly adhere to the recommended one tablet daily; exceeding this dose increases the risk of adverse effects and hypervitaminosis.

Concurrent use with other multivitamin or mineral supplements is not recommended to prevent overdose of fat-soluble vitamins (A, D, E) and iron.

Store the bottle securely out of the reach of children to prevent accidental ingestion.

In case of accidental overdose of multiple tablets, seek immediate medical attention or contact a poison control center.

Adverse Reactions

Allergic reactions to the components of the drug are possible.

Urine may turn intense yellow, which is not dangerous, as it is due to the presence of riboflavin in the drug.

Contraindications

  • Hypervitaminosis A and D;
  • Children under 4 years of age;
  • Hypersensitivity to any of the components of the drug.

Use in Pregnancy and Lactation

No data.

Pediatric Use

Contraindicated in children under 4 years of age. Prescribed for children from 4 to 7 years old.

Geriatric Use

Prescribed for children from 4 to 7 years old.

Special Precautions

The recommended dosage should not be exceeded.

Effect on ability to drive vehicles and machinery

No data.

Overdose

In case of accidental overdose, a doctor should be consulted.

Treatment: activated charcoal orally, gastric lavage, symptomatic treatment.

Drug Interactions

Concomitant use with other drugs containing vitamins A, E, D and Iron is not recommended to avoid overdose.

Phosphates and calcium salts reduce the absorption of magnesium in the gastrointestinal tract; Magnesium reduces the absorption of tetracycline.

Pyridoxine inhibits the activity of levodopa.

Storage Conditions

The drug should be stored in a dry place, out of the reach of children, at a temperature of 10-30°C (50-86°F).

Shelf Life

Shelf life – 5 years.

Dispensing Status

The drug is approved for use as an over-the-counter product.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS